Sanofi SA header image

Sanofi SA

SNY

Equity

ISIN null / Valor 1447201

NASDAQ (2026-02-20)
USD 46.76-1.31%

Sanofi SA
UMushroom community rating:

star star star star star
4.00 2 votes No rating yet
NegativeNeutralPositive

About company

Sanofi SA is a global pharmaceutical company with a rich history dating back to the 18th century. The company has a strong focus on developing advanced disease modifying treatments, particularly in the field of multiple sclerosis and rare blood disorders like hemophilia A. Sanofi has a robust pipeline of innovative therapies and has made significant contributions to the rare disease space with groundbreaking discoveries in enzyme replacement therapies for diseases like Gaucher, Fabry, and Pompe. With a strong foundation in research and development, Sanofi continues to explore new treatments and technologies to improve patient outcomes and redefine disease management.

Summarized from source with an LLMView SourceSector: Healthcare

Latest Results ():

Summarized from source with an LLMView Source

Key figures

-13.6%1Y
-1.91%3Y
0.26%5Y

Performance

72.5%1Y
61.8%3Y
49.9%5Y

Volatility

Market cap

112929 M

Market cap (USD)

Daily traded volume (Shares)

2,755,838

Daily traded volume (Shares)

1 day high/low

48.65 / 48.21

1 day high/low (USD)

52 weeks high/low

0.00 / 0.00

52 weeks high/low (USD)

Dividend ex-date

01 January, 2022

Dividend ex-date

Dividend

0.00

Dividend (USD)

Dividend yield (p.a.)

0.00%

Dividend yield (p.a.)

0.002022
0.002023
0.002024

Est dividend (USD)

0.00%2022
0.00%2023
0.00%2024

Est dividend yield

P/E ratio

10.00

P/E ratio

00.002022
00.002023
00.002024

Est P/E ratio

EPS

0.00

EPS (USD)

0.002022
0.002023
0.002024

Est EPS (USD)

Ratings & reviews

star star star star star

4.00

2 votes
Performance:
starstarstarstarstar
4.00
Innovation:
starstarstarstarstar
3.50
Society:
starstarstarstarstar
3.50
Nature:
starstarstarstarstar
3.50
Milena Klasing Chen
Switzerland, 30 Mar 2025
star star star star star
Stable
Milena Klasing Chen
Switzerland, 24 Mar 2025
star star star star star
Ok

EQUITIES OF THE SAME SECTOR

Newron Pharmaceuticals S.p.A.
Newron Pharmaceuticals S.p.A. Newron Pharmaceuticals S.p.A. Valor: 2791431
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.62%CHF 19.26
EssilorLuxottica SA
EssilorLuxottica SA EssilorLuxottica SA Valor: 497537
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
2.23%EUR 238.20
bioMerieux SA
bioMerieux SA bioMerieux SA Valor: 38147803
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.01%EUR 95.25
Siemens Healthineers AG
Siemens Healthineers AG Siemens Healthineers AG Valor: 40652181
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
2.17%EUR 42.35
Fresenius SE & Co. KGaA
Fresenius SE & Co. KGaA Fresenius SE & Co. KGaA Valor: 332902
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.04%EUR 52.06
Fresenius Medical Care AG
Fresenius Medical Care AG Fresenius Medical Care AG Valor: 520878
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.18%EUR 41.17
Evolent Health Inc
Evolent Health Inc Evolent Health Inc Valor: 28153126
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.72%USD 2.79
Vita 34 AG
Vita 34 AG Vita 34 AG Valor: 2333201
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.95%EUR 5.30
Maternus-Kliniken AG
Maternus-Kliniken AG Maternus-Kliniken AG Valor: 335800
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-2.02%EUR 0.97
QuidelOrtho Corporation
QuidelOrtho Corporation QuidelOrtho Corporation Valor: 119356965
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-4.79%USD 22.48